Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidate

Abstract The development of an affordable and accessible vaccine platform is essential for achieving global and long-term protection against COVID-19 and other emerging viral diseases. In this study, we developed a multimeric fusion protein comprising the SARS-CoV-2 receptor-binding domain (RBD) and...

Full description

Saved in:
Bibliographic Details
Main Authors: Ozi Jumadila, Muhammad Dzul Fakhri, Adam Darsono, Fernita Puspasari, Sari Dewi Kurniasih, Fifi Fitriyah Masduki, Keni Vidilaseris, Ihsanawati Ihsanawati, Anita Artarini, Marselina Irasonia Tan, Ernawati Arifin Giri-Rachman, Dessy Natalia
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-01242-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850242907959721984
author Ozi Jumadila
Muhammad Dzul Fakhri
Adam Darsono
Fernita Puspasari
Sari Dewi Kurniasih
Fifi Fitriyah Masduki
Keni Vidilaseris
Ihsanawati Ihsanawati
Anita Artarini
Marselina Irasonia Tan
Ernawati Arifin Giri-Rachman
Dessy Natalia
author_facet Ozi Jumadila
Muhammad Dzul Fakhri
Adam Darsono
Fernita Puspasari
Sari Dewi Kurniasih
Fifi Fitriyah Masduki
Keni Vidilaseris
Ihsanawati Ihsanawati
Anita Artarini
Marselina Irasonia Tan
Ernawati Arifin Giri-Rachman
Dessy Natalia
author_sort Ozi Jumadila
collection DOAJ
description Abstract The development of an affordable and accessible vaccine platform is essential for achieving global and long-term protection against COVID-19 and other emerging viral diseases. In this study, we developed a multimeric fusion protein comprising the SARS-CoV-2 receptor-binding domain (RBD) and the β-annulus (Bann) from the tomato bushy stunt virus (TBSV) as a potential subunit vaccine candidate. Molecular modeling of Bann-RBD revealed a 60-mer structure with the RBD displayed on its outer surface. The Bann-RBD gene was constructed and overexpressed in Pichia pastoris X-33. SDS-PAGE analysis of the purified Bann-RBD showed a protein band at 45 kDa, corresponding to monomeric glycosylated Bann-RBD. Peptide mapping analysis using LC-MS/MS confirmed that the expressed Bann-RBD was consistent with the designed protein fusion. The Bann-RBD protein was observed to spontaneously self-assemble into spherical nanocapsids with a diameter of approximately 50 nm. Antigenicity studies demonstrated that the purified Bann-RBD was strongly recognised by monoclonal human anti-SARS-CoV-2 spike-S1 IgG antibodies. Immunogenicity studies revealed that Bann-RBD elicited a robust humoral immune response in BALB/c mice, generating potent neutralising antibodies. Collectively, these findings suggest that the recombinant Bann-RBD produced in Pichia pastoris X-33 is a promising candidate for the development of a COVID-19 vaccine.
format Article
id doaj-art-8ad37908ece54c6d93deeb2a089965b0
institution OA Journals
issn 2045-2322
language English
publishDate 2025-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8ad37908ece54c6d93deeb2a089965b02025-08-20T02:00:08ZengNature PortfolioScientific Reports2045-23222025-05-0115111510.1038/s41598-025-01242-5Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidateOzi Jumadila0Muhammad Dzul Fakhri1Adam Darsono2Fernita Puspasari3Sari Dewi Kurniasih4Fifi Fitriyah Masduki5Keni Vidilaseris6Ihsanawati Ihsanawati7Anita Artarini8Marselina Irasonia Tan9Ernawati Arifin Giri-Rachman10Dessy Natalia11Biochemistry and Biomolecular Engineering Research Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi BandungBiochemistry and Biomolecular Engineering Research Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi BandungSchool of Life Sciences and Technology, Institut Teknologi BandungBiochemistry and Biomolecular Engineering Research Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi BandungBiochemistry and Biomolecular Engineering Research Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi BandungBiochemistry and Biomolecular Engineering Research Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi BandungThe Molecular and Integrative Biosciences Research Programme (MIBS), Faculty of Biological and Environmental Sciences, University of HelsinkiBiochemistry and Biomolecular Engineering Research Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi BandungLaboratory of Pharmaceutical Biotechnology, School of Pharmacy, Institut Teknologi BandungSchool of Life Sciences and Technology, Institut Teknologi BandungSchool of Life Sciences and Technology, Institut Teknologi BandungBiochemistry and Biomolecular Engineering Research Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi BandungAbstract The development of an affordable and accessible vaccine platform is essential for achieving global and long-term protection against COVID-19 and other emerging viral diseases. In this study, we developed a multimeric fusion protein comprising the SARS-CoV-2 receptor-binding domain (RBD) and the β-annulus (Bann) from the tomato bushy stunt virus (TBSV) as a potential subunit vaccine candidate. Molecular modeling of Bann-RBD revealed a 60-mer structure with the RBD displayed on its outer surface. The Bann-RBD gene was constructed and overexpressed in Pichia pastoris X-33. SDS-PAGE analysis of the purified Bann-RBD showed a protein band at 45 kDa, corresponding to monomeric glycosylated Bann-RBD. Peptide mapping analysis using LC-MS/MS confirmed that the expressed Bann-RBD was consistent with the designed protein fusion. The Bann-RBD protein was observed to spontaneously self-assemble into spherical nanocapsids with a diameter of approximately 50 nm. Antigenicity studies demonstrated that the purified Bann-RBD was strongly recognised by monoclonal human anti-SARS-CoV-2 spike-S1 IgG antibodies. Immunogenicity studies revealed that Bann-RBD elicited a robust humoral immune response in BALB/c mice, generating potent neutralising antibodies. Collectively, these findings suggest that the recombinant Bann-RBD produced in Pichia pastoris X-33 is a promising candidate for the development of a COVID-19 vaccine.https://doi.org/10.1038/s41598-025-01242-5COVID-19Multimeric proteinRBDSubunit vaccineβ-annulus
spellingShingle Ozi Jumadila
Muhammad Dzul Fakhri
Adam Darsono
Fernita Puspasari
Sari Dewi Kurniasih
Fifi Fitriyah Masduki
Keni Vidilaseris
Ihsanawati Ihsanawati
Anita Artarini
Marselina Irasonia Tan
Ernawati Arifin Giri-Rachman
Dessy Natalia
Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidate
Scientific Reports
COVID-19
Multimeric protein
RBD
Subunit vaccine
β-annulus
title Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidate
title_full Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidate
title_fullStr Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidate
title_full_unstemmed Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidate
title_short Development of a self-assembling multimeric Bann-RBD fusion protein in Pichia pastoris as a potential COVID-19 vaccine candidate
title_sort development of a self assembling multimeric bann rbd fusion protein in pichia pastoris as a potential covid 19 vaccine candidate
topic COVID-19
Multimeric protein
RBD
Subunit vaccine
β-annulus
url https://doi.org/10.1038/s41598-025-01242-5
work_keys_str_mv AT ozijumadila developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT muhammaddzulfakhri developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT adamdarsono developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT fernitapuspasari developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT saridewikurniasih developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT fififitriyahmasduki developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT kenividilaseris developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT ihsanawatiihsanawati developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT anitaartarini developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT marselinairasoniatan developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT ernawatiarifingirirachman developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate
AT dessynatalia developmentofaselfassemblingmultimericbannrbdfusionproteininpichiapastorisasapotentialcovid19vaccinecandidate